May contain inaccuracies · Check primary sources · Not medical advice · Not for human or animal use

Non-peptide

N-methyl cyclazodone

Also known as

N-methylcyclazodone · N-methyl-cyclazodone · NMC

Community talk. May contain inaccuracies. Not medical advice. Not a protocol. Not for human or animal use.

N-methyl cyclazodone (NMC) is a research stimulant discussed for wakefulness, motivation and getting work done. Reports include useful alertness, little benefit and stimulation that outlasts useful concentration. It is distinct from cyclazodone; their doses and timelines cannot be substituted.

What it is

  • A distinct pemoline-family compound. N-methylcyclazodone and N-methyl-cyclazodone are spelling variants of NMC. It is a small molecule, not a peptide; chemical relationship to cyclazodone or pemoline does not establish the same effects or safety. Animal context
  • The attraction is sustained alertness. People looking for energy to study, work or train describe it as a functional stimulant. That means feeling able to do tasks, which is different from measured improvement in memory, judgment or performance. Personal report Personal report

Benefits people report

  • Alertness without a strong recreational effect. A sublingual user described NMC as milder but longer-lasting than cyclazodone. Coffee accompanied the experience, so the report does not isolate NMC. Personal report
  • Training drive is disputed. A recent combined pre-workout account praised focus and drive but also described a severe crash. A separate timed Bluelight log found no improvement in sporting performance and felt anxious. Personal report Personal report

Doses people discuss

  • Oral examples: 5 mg and 15 mg. MalloryMalice described mild stimulation at 5 mg and a brief mood lift at 15 mg followed by foggy stimulation. Their 35 mg and 50 mg trials brought more pronounced adverse effects; these are individual experiments, not a recommended range. Community · Reddit
  • Other routes and reports stay separate. One report gives about 15 mg sublingually, meaning under the tongue. A Bluelight contributor described 5–10 mg once in the morning but did not specify route; neither account establishes equivalence with swallowed doses. Personal report Community · Bluelight
  • 10–40 mg oral did not reliably help another user. The oral-powder account alternated between little effect and unpleasant weakness or breathlessness. Amount alone did not predict a useful response. Personal report
  • 60–100 mg appears in a heavily confounded pre-workout account. The author combined NMC with other stimulant products and reported a severe crash. This high-amount report is preserved as a caution, not an upper safe limit. Personal report

Half-life

  • A ten-hour claim has an unclear meaning. One Reddit reply gives “10 hours for me” in a half-life discussion, without a measurement method, dose or route. It may describe felt duration; no dependable human elimination half-life was established in this review. Community · Reddit

Onset: when effects begin

  • 30–45 minutes orally in one account. The same author described 10–15 minutes after nasal use. These are route-specific subjective observations, not absorption measurements or instructions to change route. Community · Reddit
  • Delayed distress can follow an initially quiet period. After ingesting 50 mg, thrownstick reported little effect for over an hour, then distress during exercise four or five hours after posting. That places the episode roughly five to six hours or more after ingestion, not four to five hours after the dose. Personal report
  • A timed log noticed effects after 50 minutes. Leprechaun recorded 11 mg at 05:10 and effects at 06:00, but took a pre-workout containing 150 mg caffeine in between. Route was not explicitly stated. Personal report

Duration: stimulation versus useful focus

  • 6–8 hours of primary effects in one oral account. Residual stimulation exceeded 16 hours, while the initial pleasurable or focused period was much shorter. Staying awake did not mean staying productive. Community · Reddit
  • Around 12 hours, with next-day remnants in another account. Xorkoth described approximately 12 hours; MDPV_Psychosis sometimes noticed minor residual stimulation at 24 hours. Neither specified route in those posts, and these are separate accounts rather than a measured range. Community · Bluelight
  • Redosing makes a day-long log hard to interpret. The 2025 log added 15 mg at 08:40 after the initial 11 mg: 26 mg total. Background effects remained at 17:00; that timeline cannot establish duration after one dose. Personal report

Repeated use and breaks

  • Daily use and once-weekly advice both appear. A positive commenter described roughly two months of daily use and an earlier three-month period, with tolerance and several psychiatric medications involved. Another commenter advised once-weekly use; that is an opinion, not a tested cycle. Community · Reddit
  • Consecutive days can change the experience. The pre-workout author reported five consecutive days, waning euphoria after three or four days and worsening fatigue. These observations do not establish an effective break length or a safe repeated-use schedule. Personal report

What matters before interpreting the reports

  • Weakness and breathlessness deserve attention. The negative oral account described these symptoms even before adding caffeine; caffeine reportedly made them worse. The author later clarified that symptoms predated bupropion, while a separate cyclazodone trial involved flmodafinil. The cause remains unverified. Personal report
  • Other drugs can change both benefits and harms. deficiT reported 20 mg alongside Vyvanse, piracetam and aniracetam, followed by excessive stimulation and headache. That is not evidence of a compatible stack. Community · Bluelight
  • A serious clinical toxicity case exists. A 2022 conference abstract describes abnormal movements, palpitations and abnormal cardiac electrical conduction after a reported total of about 5 g over five days. Fluoxetine and aripiprazole were also prescribed; urine testing detected cyclazodone, an expected NMC metabolite, rather than confirming the original powder. Official context
  • Liver risk is uncertain, not absent. That case also had an elevated liver enzyme and muscle-injury marker. One heavily exposed patient cannot establish risk at lower amounts, and related-drug toxicity cannot supply an NMC-specific frequency; forum supplement claims do not prove protection. Official context Personal report

Community experience

  • Preferences can reverse with experience. Xorkoth initially preferred NMC, then preferred cyclazodone because NMC lasted too long and caused headaches. This is a same-person change of judgment, not two independent votes. Community · Bluelight
  • Wakefulness can coexist with worse thinking. MalloryMalice described impaired reading, memory and verbal fluency after an initial lift, plus an urge to redose. Positive replies in that thread do not cancel that experience. Community · Reddit
  • A good first day does not settle the question. The negative oral-powder author later clarified that their first NMC day had been good, followed by inconsistent responses and recurring adverse effects. Their later replies refine the opening account rather than adding new users. Personal report
  • Pre-workout enthusiasm has extra confounders. The recent enthusiastic author disclosed plans to sell or trade stock and combined multiple products. Their claim that NMC was a hidden ingredient in a branded pre-workout was explicitly uncertain and is not verified here. Personal report

What formal research adds

  • Metabolism research is not a clinical benefit study. A 2026 paper examined NMC using liver preparations and rat urine. Its abstract adds laboratory context but does not establish a human therapeutic dose, a reliable elimination half-life or the community claim that the parent compound is entirely inactive until converted. Animal context

Open in the directory ↗All STUDresearch topics →